JP2004121526A - Injection preparation support system - Google Patents

Abstract

<P>PROBLEM TO BE SOLVED: To discriminate whether the prescribed amount and the applying interval of a prescribed anticancer agent are proper, to monitor whether the accumulated administration amount of the anti-cancer agent is not larger than the amount of lifetime administration, to prepare the totalization list of injections by each hospital ward and each time zone, and to prepare a label to be stuck to a transfusion vessel. <P>SOLUTION: An injection master database, incompatibility data base, patient data base, anticancer agent prescription history data base classified by each patient, and the like, are provided. By each prescription, an incompatibility blending means blends incompatibility to prepare a comment, a pH variation blending means blends pH variation to prepare a comment, prepares an injection total list by each hospital ward, and prints necessary items and comments to a medicine bag by each patient and each application to prepare the medicine bag, and a label preparation means prepares the label to be pasted onto the transfusion vessel. <P>COPYRIGHT: (C)2004,JPO

Description

[0001]
BACKGROUND OF THE INVENTION 1. Field of the Invention The present invention relates to a system for supporting the dispensing of injections to a plurality of patients in a hospital. The present invention relates to a device provided with a medicine tally list creating means and the like.
[0002]
2. Description of the Related Art Conventionally, a large number of inpatients are hospitalized in a plurality of wards, and in a general ward where physiochemotherapy is administered to a plurality of cancer patients, each ward is required based on a doctor's prescription. It is necessary to collect and supply various types and amounts of medicines, and to supply various medicines (powder, tablets, injections and infusions, etc.) for each patient's application.
[0003]
When multiple types of injections are mixed with an infusion and applied to a patient according to a prescription prepared by a doctor, the injections may become turbid, change the appearance of sediments, decompose components, or reduce potency. In view of the fact that there are many cases, it is difficult for nurses, etc. to have sufficient pharmaceutical knowledge about these phenomena, an injection mixing support device proposed in view of Patent Document 1 has been proposed. I have.
[0004]
In the injection mixing support apparatus of Patent Document 1, a computer connected to a host computer stores a patient attribute data file, an injection prescription file, a mixing support data file, a compounding impossible data file, a caution information data file, and a compound change record file. In addition to being equipped with various master files and the like, a keyboard, a display, and a printer are also provided to display patient data, prescription injection data for the patient, and combination-related data on the display.
[0005]
Furthermore, in this injection mixing support apparatus, the pH value data of each injection is stored in the data file relating to the mixing, and the mixing order of the injections is determined based on the pH values of the plurality of injections. Can be displayed on the display. In addition, in this support device, combination-impossible data indicating whether or not a combination of two types of injections cannot be combined is stored in a combination-related data file, and a plurality of injection combinations of a plurality of prescription injections are stored. It is determined whether or not it can be blended and displayed on the display.
[0006]
In the medicine bag printing apparatus described in Patent Document 2, a computer is equipped with a medicine master file, a compounding impossible file, a pH fluctuation file, a compounding caution file, a printer, and the like. It is determined whether or not the value falls within the effective range, and if the effective range of the pH value is lost, it is regulated not to mix. In addition, this apparatus is configured to determine whether or not a plurality of prescribed drugs can be blended. In addition, in this medicine bag printing apparatus, necessary information can be printed on a patient-specific medicine bag for accommodating and accommodating a medicine for each patient according to the prescription information of the patient.
[0007]
In the medicine bag printing apparatus described in Patent Literature 3, various images and necessary character information can be printed on a medicine bag for supplying a prescribed medicine to a patient. The various images include a seasonal image, an age identification image corresponding to the date of birth and age, a face image, a patient classification image, and the like.
[0008]
On the other hand, since anticancer drugs are highly toxic drugs, the application interval from administration to administration is limited, and the prescription amount for each application is determined by the prescription amount calculation master coefficient set for each anticancer agent and the patient's It is necessary to calculate based on the body surface area, and even with the same anticancer drug, the dose is often different depending on the type (disease name) of the cancer, and the life-time dose is limited. Great care must be taken when prescribing or dispensing one or more anti-cancer agents into a drug.
[0009]
On the other hand, in order to stock multiple types of medicines to be supplied to multiple wards (nurse stations, etc.) at appropriate timing, at present, a pharmacy or pharmacy in a hospital uses a calculator or the like based on the prescriptions of multiple patients in each ward. In each ward, for example, a drug summary list of necessary drugs in the morning of the next day, a drug summary list of required drugs in the afternoon, etc. are created, and a plurality of types of drugs described in the drug summary list are created. There is also a system that supplies them to the appropriate ward.
[0010]
[Patent Document 1] JP-A-2000-311205
[Patent Document 2] JP-A-2000-113072
[Patent Document 3] JP-A-2000-218873
[0011]
With respect to the anticancer drug, the application interval and dose of the anticancer drug are determined by a physician. However, in a pharmacy, a pharmacy or a dispensing pharmacy at a hospital, the application interval or the administration of the anticancer drug is determined. Checking the amount requires various information such as the master coefficient of each anticancer drug, height and weight data of each cancer patient, and data on the last prescription time. It does not check the application interval and prescription amount, and no technique has been proposed to make it possible. The same applies to the lifetime dose, and since the data on the cumulative dose of the anticancer drug administered to each cancer patient in the past is not complete, the physician appropriately determines the lifetime dose.
[0012]
However, improper prescription of anticancer drug application intervals and dosages can have a serious effect on patients. It is desirable to be able to check whether such a technique is available, but no such technique has been proposed in the past.
[0013]
On the other hand, manually creating a list of necessary medicines for each time zone (for example, morning, afternoon, etc.) for each ward requires a great deal of labor and time, and there is a problem that calculation errors are likely to occur. On the other hand, in the case of an inpatient, etc., when a plurality of injections are mixed into an infusion and an infusion is performed, information such as a patient name, a hospital room number, and the name of the injection to be mixed is filled in a transfusion container such as an infusion bottle. It is usual to fill in the dose directly. However, in this case, it takes time and effort to fill in the necessary items, and if the patient name or the like is erroneously written, it cannot be rewritten and becomes troublesome.
[0014]
The object of the present invention, in the injection drug dispensing support system, to be able to determine whether the prescribed anticancer drug is appropriate, to be able to create a total list of multiple types of injections by ward time zone, And making a label that can be easily attached to an infusion container.
[0015]
According to a first aspect of the present invention, there is provided a system for supporting dispensing of an injection for a plurality of patients in a hospital. The drug identification information and the standard amount information for identification are set in advance, and, for a plurality of anticancer drug injections, the application interval information and the prescription amount calculation master coefficient for each anticancer agent are also set in advance for storage media. Injection drug master database and patient identification information and injectable drug prescription information for each of a plurality of patients are stored in a storage medium, and for cancer patients, a disease database and height and weight information are further stored. Using the information of the injection medicine master database and the patient database, for each cancer patient, whether the prescribed amount of the anticancer drug for each application and whether the application interval is appropriate or not. Is obtained by a proper determination unit anticancer agent determines.
[0016]
The above information on injections other than the anticancer drug is stored in the injection drug master database. For each anticancer drug, drug identification information and standard amount information, application interval information and prescription amount calculation are provided. For example, the master coefficient is stored.
The patient database stores the above-mentioned information on patients other than cancer patients. For cancer patients, patient identification information, injection prescription information, prescription amount information of anticancer drugs for each application, and the like are stored. Is stored.
[0017]
Therefore, the anticancer drug appropriateness determination means uses the information of the injection drug master database and the patient database to determine, for each cancer patient, whether the prescribed amount of the anticancer drug for each application and the application interval are appropriate. . Therefore, independent of the prescribing physician, the injection medicine dispensing support system can determine whether the application interval and the prescribed amount of the anticancer drug prescribed to the cancer patient are appropriate, so that a prescription error regarding the anticancer drug can be reliably detected. In addition, medication errors can be prevented.
[0018]
Here, the following configuration may be employed in addition to the configuration of the first aspect.
The injectable drug master database further includes, for the anticancer drug, lifetime dose information regarding a lifetime dose indicating a limit of the lifetime administration of each anticancer drug, and one or more anticancer drugs in each of a plurality of cancer patients. An anticancer drug prescribing history database in which prescription history information is stored in a storage medium is provided, and the anticancer drug adequacy determining means uses data of an injection drug master database, a patient database, and an anticancer drug prescribing history database, It is also determined for a cancer patient whether the cumulative dose is equal to or less than the lifetime dose for each anticancer drug (Claim 2).
[0019]
By the anticancer drug adequacy determining means, using the data of the injection drug master database, the patient database and the anticancer drug prescription history database, for each cancer patient whether or not the cumulative dose for each anticancer drug is less than the lifetime dose Since it is also possible to check that the cumulative dose administered to each cancer patient does not exceed the lifetime dose separately from the prescribing physician, it is possible to reliably prevent the overdose of the anticancer drug.
[0020]
For each of the plurality of types of injections, a combination contraindication database in which information on injection contraindications and combination contraindications are preset and stored in a storage medium is provided (claim 3). Using the information of this combination contraindication database, it becomes possible to know the combination of injections that are contraindicated when combining a plurality of injections and the contraindication phenomenon.
[0021]
Using the information of the injection medicine master database, the combination contraindication database and the patient database, a combination contraindication determining means for determining whether a combination contraindication occurs for a plurality of types of injections for each application applied to each patient is provided ( Claim 4).
Therefore, it is possible to determine whether or not a combination contraindication occurs for a plurality of types of injections for each application to be applied to each patient by the combination contraindication determination means.
[0022]
Using the information in the patient database, information on one or more types of injections for each application to be applied to each patient, application time zone information, patient identification information, and information on the incompatibility determined by the incompatibility determination means And a means for creating a separate medicine bag for each patient to print the information on a predetermined medicine bag to create a separate medicine bag for each patient is provided (claim 5). The medicine bag created by the patient-specific medicine bag making means includes, for example, a combination of a patient name, an application time period (for example, morning, noon, evening), one or more injection medicine names, and an injection medicine causing contraindications. Information such as the contraindications (for example, cloudiness) is printed.
[0023]
The injection medicine master database has information on the amount of water contained in each injection medicine, the amount of ions of a plurality of types of ions, the amount of calories, and the total amount of nitrogen (claim 6). Therefore, for each of the plurality of injections to be applied to the patient, the amount of water, the amount of ions of a plurality of types of ions, the amount of calories, and the total amount of nitrogen can be known. , The total amount of water, the total amount of ions of a plurality of types of ions, the total amount of calories, and the total amount of nitrogen can be known.
[0024]
The patient-specific application-specific bag creating means calculates a total amount of water, a total amount of ions, a total amount of calories, and a total amount of total nitrogen contained in one or more injections for each application, The information is also printed on a patient-specific medicine bag (claim 7). Since the information as described above is printed on the medicine bag, the information can be easily known.
[0025]
An injection medicine dispensing support system according to claim 4 is a system for supporting dispensing an injection medicine to a plurality of patients in a hospital, wherein patient specific information and injection medicine prescription information relating to each of the plurality of patients are stored in a storage medium. For inpatients, a patient database that further stores ward information specifying the inpatient ward of each patient, and using the information in the patient database, is applied at each time zone such as morning or afternoon in each of the plurality of wards. And a ward-by-ward injection medicine total list creating means for summarizing a plurality of types of injection medicines by type and creating a list thereof.
It should be noted that a ward is not limited to a ward for each building, but also a nurse station on each floor of the hospital. The ward-specific injection medicine total list creating means can compile a plurality of types of injection medicines applied in each time zone such as morning and afternoon in each of the plurality of wards by type, and create a list thereof. A plurality of types of injections to be supplied to the pharmaceutical preparation can be efficiently prepared, and the efficiency of dispensing work can be improved.
[0026]
Here, the following configuration may be adopted in addition to the configuration of the eighth aspect.
Using the information of the patient database, prepare information on one or more injections to be mixed with the infusion to be applied to each patient, application time zone information, and patient identification information, and use the information as a predetermined peelable label. Label producing means for producing a label for infusion by printing on paper is provided (claim 9). The infusion label created by the label creating means is printed with, for example, the drug name of one or a plurality of injections, the application time zone (for example, morning, noon, evening), the patient's name, and the like. Since the label for infusion is printed on a peelable label paper, it can be easily peeled off and attached to an infusion container such as a drip bottle, and can be easily peeled off if it is erroneously attached.
[0027]
BEST MODE FOR CARRYING OUT THE INVENTION
Hereinafter, an embodiment of an injection medicine dispensing support system according to the present invention will be described with reference to the drawings. This injectable drug dispensing support system allows multiple inpatients to be hospitalized in multiple wards, and in a general hospital where multiple cancer patients also receive physiochemotherapy, multiple inpatients and outpatients can receive injectable drugs. Is a system that supports dispensing.
[0028]
FIG. 1 shows a desktop personal computer 2 (personal computer) constituting an injection medicine dispensing support system 1 and three printers 3 to 5 connected to the personal computer 2. For example, it is installed in a department (for example, a pharmacy department) that performs dispensing work in a hospital. FIG. 2 is a block diagram of the injection medicine dispensing support system 1. The personal computer 2 includes a CPU 6, a ROM 7, a RAM 8, a plurality of hard disks 9 (HD) for rewritably storing various programs and data, a hard disk drive 10 (HDD) thereof, a CD drive 12 (CDD) for driving a CD 11, The personal computer 2 includes an output interface 13 (I / O), a keyboard 14, a liquid crystal display 15 (LCD), and the like. Third printers 3 to 5 are connected.
[0029]
For example, an OS of “WINDOWS” is installed in the personal computer 2, and various routines (programs) and various databases described later that operate on the WINDOWS are stored. FIG. 3 shows the relationship between the main database and the main function achieving means 20 to 25 in the injection medicine dispensing support system 1.
As the above-mentioned database, an injection medicine master database DB1, a combination contraindication database DB2, a patient database DB3, a patient-specific anticancer drug prescription history database DB4, and the like are stored in the hard disk 9. The above-mentioned function achieving means 20 to 25 include combination contraindication determining means 20, pH fluctuation determining means 21, anticancer drug adequacy determining means 22, ward-based injection medicine total list creating means 23, patient-specific applied medicine bag creating means 24, A label creating unit 25 and the like are provided, and the lines and arrows in the figure indicate the flow of information used by the function achieving unit.
[0030]
Next, the databases DB1 to DB4 will be described.
First, the injection medicine master database DB1 will be described.
As shown in FIG. 3, FIG. 4 (a) and FIG. 5, this injection medicine master database DB1 stores in advance medicine identification information for specifying an injection medicine and standard amount information for each of a plurality of types of injection medicines. In addition to the setting, for a plurality of injections of anticancer drug, application interval information for each anticancer drug and a master coefficient for calculating the prescription amount of anticancer drug were also set in advance and stored in the first file of the hard disk 9 of the personal computer 2. Things. This injection medicine master database DB1 includes, for example, medicine identification data for each of about 1000 kinds of injection medicines including a plurality of kinds of injections of anticancer medicines and, for example, about 50 kinds of injections of anticancer medicine injections. Includes data specific to anticancer drugs.
[0031]
FIG. 5 shows an example of the injection medicine master data (the display state on the screen of the LCD 15) of each injection medicine in the injection medicine master database DB1, and this example is an example of "Bisorubon 4 mg". As shown in FIG. 5, the master data of each injection includes at least a drug code, a drug name, an abbreviation, a standard amount, a drug category (A is an ampule, V is a vial), and a storage category as information for specifying a drug. (Room temperature, cold place), and further, as information of the component amount, the amount of water, Na ⁺ , K ⁺ , Ca ⁺⁺ , Mg ⁺⁺ , Cl ⁻ Includes data on the ion amount, calories and total nitrogen amount of multiple types of major ions, such as the lower limit pH, sample pH (self pH), upper limit pH, acidic buffering capacity, and alkaline buffering capacity. Includes such data.
[0032]
The master data of each injection is, in addition to the above data, for each injection of anticancer drug, an anticancer drug category indicating that the drug is an anticancer drug, a master coefficient for calculating an anticancer drug prescription amount, and a cancer disease name. It includes data such as separate application intervals (days) and the acceptable lifetime dose for each cancer patient. The above-mentioned application intervals and lifetime doses for each disease name can be set for dozens of cancers for which the anticancer drug is prescribed.
[0033]
Since the amount of the anticancer agent is prescribed according to the body surface area of the cancer patient, the unit of the above master coefficient is mg / m ² Since the anticancer drug is administered at an application interval peculiar to the anticancer drug from administration to administration, application interval data is also set, and lifetime dose data is also set. The unit of the lifetime dose is mg / m ² However, the absolute amount may be defined in units of mg, and the lifetime dose may be set in common for a plurality of cancers regardless of the disease name.
[0034]
In the case of creating the injection medicine master database DB1, the work of displaying the initial screen shown in FIG. 5, inputting each data (information) in a plurality of data entry fields, and storing the data in the first file is performed for a large number of injection medicines. Each of them can be created by executing each of them. In a state where the master data of the desired injection medicine stored in the first file is read and displayed on the screen, a part of the data is corrected, It is also possible to delete all of them and then store them again in the first file.
[0035]
Next, the incompatibility database DB2 will be described.
As shown in FIG. 3, FIG. 4 (b), and FIG. 6, the combination contraindication database DB2 stores in advance information such as injectables that are contraindicated for each of a plurality of types of injections and comments on contraindications. This is set and stored in the second file of the hard disk 9 of the personal computer 2. This combination contraindication database DB2 contains, for each of a plurality of injections that are contraindicated with one or more other types of injections, among a large number of injections registered in the injection medicine master base data DB1, A comment indicating a contra-injection drug, a contra-inhibitory phenomenon, or the like that causes a contraindication is set and stored in advance. It should be noted that compounding contraindications are concepts that include both compounding prohibited and compounding permitted but cautioned.
[0036]
FIG. 6 shows an example of the combination contraindication data (a state displayed on the screen of the LCD 15) of each combination drug in the combination contraindication database DB2, and this example is an example of “Bisorubon 4 mg”. As shown in FIG. 6, the combination contraindication data of each injection includes at least data such as a drug code and a drug name as information for specifying a reference injection (for example, “bisorbon 4 mg”). Information (drug code, drug name) for specifying one or more types of injectable drugs that cause incompatibilities with the injectable drug serving as this reference and data on comments indicating incompatibility phenomena and the like are set and stored in advance. .
[0037]
For example, in the line of "aspara K", "aspara K" is contraindicated in combination with "visorubone 4 mg", and when bisorbon and aspara K are mixed in an infusion solution (TZ500 ml), it dissolves although it becomes cloudy immediately after that. As long as it can be used. “White turbidity (immediately after)” is the content of the contraindicated phenomenon, and “Useable when dissolved in 500 ml of TZ” is a commentary. The same applies to other injections (Strong Mino C, Kefrin 1 g, Siomarin 1 g,...) Which cause contraindications for “Bisorubon 4 mg”.
[0038]
However, FIG. 6 is a part of a list of injections that are contraindicated for incorporation of “Bisorubon 4 mg” and shows only a part of the display screen. Moreover, the injections shown in the figure are contraindicated for "Bisorubon 4 mg", but those that can be used happen to be shown. Information about injections is also stored.
[0039]
Next, the patient database will be described.
As shown in FIG. 3, FIG. 4 (c), FIG. 7, and FIG. 8, the patient database DB3 inputs patient identification information and prescription information for each of a plurality of patients (inpatients and outpatients), and The information is stored in the third file of the hard disk 9 and, for the cancer patient, the disease name, height and weight of each patient are further input and stored in the third file. The patient database DB3 includes patient identification data and injection drug prescription data for each patient. FIG. 7 shows an example of data relating to a certain patient (display state on the screen of the LCD 15). This screen is also a screen for inputting prescription information (prescription data) while referring to a prescription. FIG. 8 is a window screen showing prescription-related information that can be displayed in the screen of FIG. The screen in FIG. 7 and the screen in FIG. 8 can be printed out.
[0040]
As shown in FIG. 7, the patient identification information includes at least data such as the patient ID, kana name, kanji name, gender, date of birth, age, medical department, ward, ward, and the name of the doctor in charge. In the case of a patient, the information further includes data such as height, weight, disease name code, abbreviation, and disease name. In the case of a cancer patient, the body surface area is determined from the height and weight as described later, and the dose (prescription amount) of the anticancer drug is determined according to the body surface area.
[0041]
As shown in FIG. 7 and FIG. 8, the prescription information other than the anticancer drug includes prescription data of injections to be applied to “morning”, “lunch”, and “evening” in the application time zone for a plurality of days. include. For example, the first group (Aquinetone 5 mg, ephedrine, FOY 100 mg,...) May receive an injection to be administered “morning” over a specified period (June 15, 2002 to June 18, 2002). The second group (Innovan 100 mg, saline 20 ml, ...) is an injection to be administered "lunch" and the third group (Solita T-35 500 ml, 100 mg Adna, ...) "Evening" is an injection to be administered. Note that the application time zones “morning”, “daytime”, and “evening” are merely examples, and there are application time zones such as “9:00 at night” and “before going to bed”.
[0042]
FIG. 9 is an example of a window screen that can be displayed in association with FIGS. 7 and 8, and is an example of a screen displaying a daily injection drug usage list 17 for each patient. -5 can be printed out. Since the patient database DB3 stores prescription information for each of a large number of patients for each patient, the initial screen shown in FIG. 9 is displayed on the screen, and when the patient ID and the patient name are input, the patient database DB3 is displayed. The corresponding information is read from the system, and the data on the amount of the injection used for each type of injection as shown in FIG. 10 is created and displayed. 9 files. Such a list of the daily injection amount for each patient can be effectively used when various injections are procured from the outside.
[0043]
Since the administration form of the anticancer agent is completely different from that of an injection other than the usual anticancer agent, the prescription information of the anticancer agent for each of a plurality of cancer patients is, for example, as shown in FIG. FIG. 10 shows an example of the “cancer chemotherapy protocol table” displayed on the screen, and is a prescription input screen as in FIG. 7. Information for specifying a patient, a ward, a doctor, a medical department, and the like are the same as in FIG.
[0044]
The prescription information of the anticancer drug includes ampule and vial images, drug code, drug name, daily dosage, administration method and administration route information, as well as date information specifying the application date, and administration for each application date. It contains information such as information specifying the anticancer drug and dosage information. The prescription information of the anticancer drug is rewritably stored in a file on the hard disk and can be modified, and the “cancer chemotherapy protocol table” shown in FIG. 10 is displayed in the form shown in FIG. 10 or in a predetermined form. It can also be printed out.
[0045]
In the cancer chemotherapy protocol table, information on the administration history of the anticancer drug (for example, history for two months) and information on the scheduled application of the anticancer drug (for example, up to two months ahead) are also set and stored. Is done. In addition, since the images of ampules and vials are displayed in color, it is advantageous in preventing mistakes in the prescription and administration of injections, and the display data for displaying the images of ampules and vials in color is stored in the hard disk in advance. It is read from a certain anticancer drug labeling database.
[0046]
7, 8, and 10, data for a predetermined period (for example, two months) is stored in the patient database DB <b> 3, and the prescription information after the predetermined period has elapsed is stored in another file on the hard disk 9. You. However, regarding the prescription information of the anticancer drug, the latest prescription information for the predetermined period is also stored redundantly in the prescription history database DB4. 7 to 10, it is possible to input, set, correct, or delete patient identification information and prescription information, and the data after the input or correction is stored in the third file. You.
[0047]
Here, in the case of cancer patients, administration history data is saved for each anticancer drug, and for each prescription of the anticancer drug, the cumulative dose is monitored so that it does not exceed the lifetime dose set for the anticancer drug There is a need to. Therefore, as shown in FIGS. 3, 4 (d) and 11, a patient-specific anticancer agent prescription history database DB4 is also provided.
FIG. 11 shows an outline of an example of a data structure of a patient-specific anticancer drug prescription history database DB4. The prescription history database DB4 is provided for a large number of cancer patients who have been examined at this hospital and administered anticancer drugs. In each case, information on the history of the prescription of the anticancer drug from the past to the present is stored in the fourth file of the hard disk 9 of the personal computer 2 for each type of the anticancer drug.
[0048]
FIG. 11 is an example showing the anticancer drug prescription history of one patient, and includes patient identification information and anticancer drug prescription history information. The patient identification information includes data such as a patient ID and a patient name, and the anticancer drug prescribing history information includes, for each cancer disease name, for each anticancer drug (denoted by a drug code), for the past to present doses. Data is stored. The prescription history database DB4 is automatically created from the data in the patient database DB3 by a predetermined anticancer agent prescription history data creation routine, and is stored in the fourth file while being updated. Using the data of this prescription history database DB4, the cumulative dose from the past to the present of one or more kinds of anticancer drugs administered for each disease in each cancer patient is calculated, and for each prescription of the anticancer drug, The cumulative dose is monitored so as not to exceed the lifetime dose, which will be described later in detail.
[0049]
However, in the above-mentioned prescription history database DB4, in addition to the anti-cancer drug prescription history information as shown in FIG. 11 or instead of the anti-cancer drug prescription history information as shown in FIG. For each type, information on the cumulative dose of the anticancer drug administered from the past to the present may be stored while being updated.
[0050]
Next, each function achieving means 20 to 25 shown in FIG. 3 will be briefly described.
The combination contraindication determination means 20 uses the information in the injection medicine master database DB1, the combination contraindication database DB2, and the patient database DB3 to determine whether a combination contraindication occurs for a plurality of types of injections applied to each patient for each application. To do. The combination contraindication determining means 20 includes the personal computer 2 and a combination contraindicated judgment processing routine stored in the hard disk 9 or the ROM 7 (see FIGS. 12 and 13). The routine means a program for executing a group of data processing.
[0051]
The pH fluctuation determination means 21 uses the information of the injection medicine master database DB1 and the patient database DB3 to mix the plural kinds of injection medicines for each application to be applied to each patient into a common infusion, which is not preferable for the pH fluctuation (substantially). This is to determine whether or not a typical pH change occurs. In addition to strictly calculating this pH fluctuation, it is possible to make a rough judgment based on the acidic buffering capacity and the alkaline buffering capacity of a plurality of prescription injections. The pH change determination means 21 is mainly composed of the personal computer 2 and a pH change determination processing routine stored in the hard disk 9 or the ROM 7 (see FIGS. 14 and 15).
[0052]
The anticancer drug adequacy determining means 22 uses the information in the injection medicine master database DB1 and the patient database DB3 to determine, for each cancer patient, the prescribed amount of the anticancer drug for each application and whether the application interval is appropriate. judge. Moreover, the anti-cancer drug adequacy determining means 22 uses the information of the anti-cancer drug prescribing history database DB4 in addition to the information of the above-mentioned databases DB1 and DB3 to determine the cumulative dose for each anti-cancer drug for each cancer patient for a lifetime. It is also determined whether the dose is exceeded. The anti-cancer drug suitability determining means 22 includes the personal computer 2 and an anti-cancer drug suitability determination processing routine stored in the hard disk 9 or the ROM 7 (see FIGS. 16 and 17).
[0053]
The ward-specific injection medicine total list creating means 23 uses the information in the patient database DB3 to totalize a plurality of types of injection medicines to be applied in each application time zone in each of the plurality of wards, and create a list thereof. I do. The ward-specific injection medicine total list creating means 23 includes the personal computer 2, a ward-specific injection medicine total list creation processing routine stored in the hard disk 9 or the ROM 7 (FIG. 18), and the printer 3.
[0054]
The patient-specific application-specific medicine bag creating means 24 uses the information in the patient database DB3 to provide information on one or more types of injections for each application to be applied to each patient, application time zone information, patient identification information, and Information on the combination contraindications determined to be generated by the contraindication determining means 20 is created, and the information is printed on a predetermined medicine bag to create a patient-specific medicine bag 26 (see FIG. 22). Further, the patient-specific medicine bag creating means 24 is configured to calculate a total water content, a total ion amount of a plurality of ions, a total calorie, and a total nitrogen amount contained in a plurality of types of injections contained in the patient-specific medicine bag 26. Is also printed on the patient-specific medicine bag 26. The patient-specific medicine bag creating means 24 includes the personal computer 2, a patient-specific medicine bag creation processing routine stored in the hard disk 9 or the ROM 7 (see FIGS. 21 and 22), and the printer 4.
[0055]
The label creating means 25 creates information on one or a plurality of injections to be mixed with the infusion to be applied to each patient, application time zone information, and patient identification information using the information in the patient database DB3. Is printed on a predetermined peelable label paper to prepare an infusion label. The label creating means 25 includes the personal computer 2, a label creating process routine stored in the hard disk 9 or the ROM 7 (see FIGS. 23 and 24), and the printer 5.
[0056]
Next, the contents of the six function achieving means 20 to 25 will be described in order.
First, the combination contraindication determination processing routine will be described with reference to FIGS. As shown in FIG. 12, after the start of this routine, an initial screen as shown in FIG. 7 is displayed on the LCD 15, and the operator inputs a patient ID (S1). Next, the patient identification data and the injection prescription data are read from the patient database DB3 and displayed on the screen as shown in FIG. 7 (S2).
[0057]
Next, in S3, the operator specifies a prescription to be determined. For example, the prescription of the first group in FIG. 7 may be specified on the screen, the prescription may be specified through data input of the date and application time zone, or the window screen of FIG. 8 may be displayed. May be specified on the screen. Note that a plurality of prescriptions may be specified collectively. Next, in S4, for a plurality of injections in the specified prescription, the combination contraindication database DB2 is searched for the contraindication between each prescription injection and another prescription injection. For example, assuming that the prescription of the first group in FIG. 7 is designated, the data of the incompatibility database DB2 is searched for ephedrine, FOY, etc. as propellants that cause incompatibility with 5 mg of aquinetone. I do. Similarly, a search is made as to whether or not FOY,. Other prescription injections are searched similarly.
[0058]
Next, in step S5, when a pair of an injectable drug that is contraindicated is detected, a comment on the injectable drug pair and the contraindicated drug is displayed, and information on the contraindicated phenomenon among the comments is stored in a predetermined file of the hard disk 9. Remember. For example, when 4 mg of bisorbon and 500 μm of methicobar are contained in the prescription injection, it is detected that the pair of injections causes a contraindication for determination, and the screen is displayed as shown in FIG. Will be displayed. Information on the above contraindications is displayed, such as "Pale orange red change (immediately after)". Information on the combination contraindications detected by this combination contraindication determination routine is printed on a medicine bag in a patient-specific application-specific medicine bag creation routine, as described later. However, an arrangement may be made in which a comment part (for example, “usable for dissolution, etc.”) of the comment is also displayed, and the information is also printed on the medicine bag.
[0059]
Next, the pH change processing routine will be described with reference to FIGS.
As shown in FIG. 14, after the start of this routine, an initial screen as shown in FIG. 7 is displayed on the LCD 15, and the operator inputs a patient ID (S10). Next, the patient identification data and the injection prescription data are read from the patient database DB3 and displayed on the screen as shown in FIG. 7 (S11). Next, in S12, the operator specifies a prescription to be determined. For example, the prescription of the first group in FIG. 7 may be specified on the screen, the prescription may be specified through data input of the date and application time zone, or the window screen of FIG. 8 may be displayed. A prescription may be specified on the screen.
[0060]
Next, in S13, the data of the prescription injection is read from the injection database DB1, and display data for displaying the pH change table is created and displayed as a screen as shown in FIG. In FIG. 15, the sample pH value (self pH value), the lower limit pH value, the upper limit pH value, the acidic buffer capacity (strong and weak), the alkaline buffer capacity (strong and weak), etc. are shown by triangles for each injection drug. Have been. It should be noted that a strong acidic buffering ability indicates that it is less susceptible to the effect of a stronger acid than one, and a weak one is the opposite. A strong alkaline buffering capacity indicates that it is less susceptible to an alkali that is stronger than yourself, while a weaker capacity is the opposite.
[0061]
Next, in S14, a calculation process for determining a pH fluctuation that may occur when combining a plurality of prescribed injections is executed. As this operation processing, two operations are executed. As the arithmetic processing (I), an arithmetic operation of calculating the pH value after blending all the injections with a predetermined arithmetic expression using the pH values and the doses of the plurality of injections is executed. If the pH value of the infusion solution after the compounding is between the lower limit pH value and the upper limit pH value of each injection, it is determined that there is no pH change, otherwise, for the relevant injection, It is determined that a pH change has occurred.
[0062]
In the calculation process (II), when the sample pH value of one of the two injections is out of the range between the lower limit pH value and the upper limit pH value of the other injection 2, the acidic buffer is used. It is determined based on the capacity and alkaline buffer capacity. For example, in FIG. 15, although the sample pH value of “Rasix 20 mg” deviates from the lower limit pH value and the upper limit pH value of “Aquinetone 5 mg” to the alkaline side, the alkaline buffer capacity of “Aquinetone 5 mg” is “weak”. , The acidic buffer capacity of "LASIX 20 mg" is "weak", so that substantial pH fluctuation does not occur. If one acidic buffer capacity is “strong” (or “weak”) and the other alkaline buffer capacity is “weak” (or “strong”) for a pair of injections, substantial pH fluctuation Is determined to occur.
[0063]
By executing the above-described arithmetic processing for all pairs of injections for a plurality of all injections in the designated prescription, it is determined whether or not substantial pH fluctuation occurs. As a result of the above calculation processes (I) and (II), injectable drugs that may cause substantial fluctuations in pH are not automatically added in S15 in FIG. It is created, displayed, and stored either manually or by screen input. It should be noted that a comment relating to pH fluctuation described later may be created by adding a judgment based on the experience or intuition of a pharmacist or a doctor.
[0064]
The comment in that case is, for example, "Note of pH in the same syringe: 3-2". However, 3-2 is the number of a pair of injections in a certain prescription, meaning that if injections 2 and 3 are mixed, the pH changes, so that injection 2 should not be mixed with injection 3. I do. However, in the example shown in FIG. 15, since no substantial pH fluctuation occurs, no comment is created and no comment is displayed in the comment display column (comment input column). This comment is printed on the medicine bag 26 when the medicine bag 26 for each patient to be described later is printed.
[0065]
Next, the anticancer agent appropriateness determination processing routine will be described with reference to FIGS. As shown in FIG. 16, after the start of this routine, an initial screen as shown in FIG. 7 is displayed on the LCD 15, and the operator inputs a patient ID (S20). Next, patient identification data, height (H) and weight (W) data, disease name data, anticancer drug prescription data, and the like are read from the patient database DB3 and displayed on the screen as shown in FIG. 7 (S21). .
[0066]
Next, in S22, the operator specifies a prescription to be determined. For example, on the screen, any of the prescriptions of the first to third groups in FIG. 7 may be specified, or the prescription may be specified through data input of the date and the application time zone (morning, noon, evening). Alternatively, the prescription may be specified on the screen while the window screen of FIG. 8 is displayed. Next, in S23, the data of the anticancer drug contained in the designated prescription is read from the injection medicine database DB1, temporarily stored in the memory of the RAM 8, and then the application interval for each anticancer drug is determined based on the prescription information. A calculation is performed (S24), and it is determined whether or not the application interval is appropriate (S25).
[0067]
In this case, for each anticancer drug, the determination at S25 is performed by comparing the application interval set in the prescription with the application interval of the corresponding anticancer drug read from the injection drug database DB1, and the determination result is obtained. Is No, a warning comment (for example, “Warning: application interval of anticancer agent... Is not appropriate!” Etc.) is displayed in S26 and stored in the RAM 8 memory. When this warning is displayed, the contents of the prescription are partially changed by widening the application interval or changing the type of anticancer drug based on the instruction of the doctor in charge, and the data in the patient database DB3 is deleted. Since the copy is changed, the process returns to S21, and the processes after S21 are executed again.
[0068]
If the determination in S25 is Yes, a message to that effect may be displayed. If the determination in S25 is Yes, in S27, the body surface area A of the patient is calculated using the data of the height H and weight W of the patient using the calculation formula shown in the drawing. In the arithmetic expression of S27, the multiplier of W (upper suffix) is 0.444, and the multiplier of H (upper suffix) is 0.663. In S28, a reference value K for calculating the prescription amount of the anticancer agent is calculated for each of the prescribed anticancer agents according to the following equation: K = master coefficient × body surface area A. Next, in S29, it is determined whether or not the prescribed amount of the anticancer agent is within the range of 0.70K to 1.30K for each anticancer agent. If the determination is No, a warning comment (for example, "Warning: prescription amount of anticancer agent ... is not proper!" Is displayed and stored in the memory of RAM 8 (S30). When the determination in S29 is Yes, it may be displayed that the prescribed amount of the anticancer agent is appropriate.
[0069]
As described above, it is determined whether the amount of the anticancer agent prescribed is within the range of 0.70K to 1.30K, because the prescribed amount determined by the above master coefficient and body surface area A is a tentative guideline. This is because the amount is merely an amount, and the doctor in charge has a range in which the prescription amount can be increased or decreased in consideration of the patient's age, physical strength, physical condition, and the like. When the above warning is displayed, the prescription content is partially changed such as changing the prescription amount of the anticancer drug based on the instruction of the doctor in charge, and the data of the patient database DB3 is partially changed. Then, S21 and the subsequent steps are executed.
[0070]
Next, when the determination in S29 is Yes, the process proceeds to S31, and in S31, each anticancer drug prescription history data relating to the patient is read from the anticancer drug prescription history database DB4, and the prescription history data is then read. The cumulative dose of the anticancer drug is calculated and displayed for each anticancer drug (S32). Next, in S33, the lifetime dose is calculated for each anticancer drug based on the characteristic data of the anticancer drug read from the injection drug database DB1 in S23, and in S34, the cumulative dose is calculated for each anticancer drug. By determining whether the dose is equal to or less than the lifetime dose, it is determined whether the cumulative dose is appropriate for each anticancer drug.
[0071]
Next, if the determination in S34 is No, in S35, a warning comment (for example, "The anticancer drug... Exceeds the lifetime dose!") Is displayed and stored. If the above warning comment is displayed, the contents of the prescription are changed, for example, by changing the type of the anticancer drug, based on the instruction of the doctor in charge, so that the process returns to S21, and the steps after S21 are repeated. Be executed. If the determination in S34 is Yes, this may be displayed.
[0072]
If the determination in S34 is Yes, the process moves to S36, and in S36, the data of the anticancer drug prescription history database DB4 is updated for each of the anticancer drugs prescribed this time, and no confirmation key is input thereafter. In this case, the process returns to S22, and the steps from S22 are repeated. Therefore, another prescription can be specified as the prescription to be determined, and the same anticancer drug appropriateness determination can be performed as described above. Finally, when the confirmation key is input, this routine ends.
[0073]
As described above, by the automatic data processing of the anticancer drug adequacy determination routine, it is possible to determine whether the application interval and the prescribed amount of the anticancer drug prescribed to the cancer patient are appropriate separately from the prescribed doctor. Therefore, it is possible to reliably detect a prescription error relating to the anticancer agent and prevent a medication error of the anticancer agent. In addition, since the cumulative dose can be monitored for each anticancer drug so as not to exceed the lifetime dose, excessive administration of the anticancer drug can be reliably prevented.
[0074]
Next, a ward-specific injection medicine total list creation processing routine will be described with reference to FIGS. FIG. 19 shows a display screen of the ward-by-ward patient tallying process created by another routine prior to the execution of the routine of FIG. 18. In this screen, the patient ward is changed or the discharged patient data is displayed. Or can be deleted.
In the patient total table by ward, a patient ID, a ward, a doctor's name, a registration date, an issuance date, and the like are set in association with each other for a plurality of inpatients. It can be printed by the printer 3 which has designated the "another patient summary table".
When data on a ward or the like is changed by this ward-specific patient tallying process, the corresponding data in the data in the patient database DB3 is automatically corrected. In a state where the ward-specific patient tally table is prepared by the ward-specific patient tally processing, the ward-specific injectable medicine total list creation processing routine of FIG. 16 is executed.
[0075]
When the routine of FIG. 18 is started, an initial screen, which is the screen of FIG. 20, is displayed (S40), and then the ward, date, time zone, etc. are specified on the screen. The “ward” is not limited to the ward defined by the building, but is a concept including “nurse stations” on each floor of the ward. The time zone is a time zone such as morning and afternoon, and “morning” includes “morning” and “day” of the application time zone, and “afternoon” includes “evening” and “night 9” of the application time zone. "Time", "before going to bed" and the like. It should be noted that, instead of the morning and afternoon time zones, it is also possible to specify the application time zone (morning, noon, evening).
[0076]
Next, in S42, prescription injection medicine data for a plurality of patients in the designated ward, date, and time zone is read from the patient database DB3, and a calculation of aggregation is performed for each injection medicine (S43). When all tabulation operations are completed, it is determined whether or not an issuance key has been input (S45). If No, the process returns to S41 and repeats S41 and subsequent steps. Print data for printing the ward-specific injectable medicine total list 27 as described above, and temporarily store the data in the RAM 8. Then, in S47, the ward-specific injectable medicine total list 27 is designated by the designated printer 3. Is printed, and when all the lists have been printed, this routine ends.
[0077]
In this way, it is possible to easily create the ward-specific injection medicine total list 27, so that a plurality of types of injections to be delivered to the ward (nurse station) based on this list can be efficiently prepared in the pharmacy department without excess or shortage. However, it can be stored in a delivery box or the like, and can be reliably delivered to a ward at an appropriate timing.
[0078]
Next, a description will be given, with reference to FIGS. After the start of this routine, an initial screen as shown in FIG. 7 is displayed, and a patient ID is input on the screen (S50). Next, in S51, a prescription to be created for a medicine bag is designated on the screen. At this time, the prescription is specified by inputting or specifying the data of the date and the application time zone. In this S51, a plurality of prescriptions may be specified collectively.
[0079]
Next, in S52, patient specific data, prescription injection data corresponding to the specified prescription, and the like are read from the patient database DB3 and stored in the memory of the RAM 8. Next, in S53, the comment on the combination contraindication obtained by the combination contraindication determination processing executed for the same target (prescription) and stored in the hard disk 9 is searched by the above-described combination contraindication determination routine. Next, in S54, a comment on the pH fluctuation obtained in the pH fluctuation determination processing executed for the same target (prescription) and stored in the hard disk 9 is searched by the above-mentioned pH fluctuation determination routine.
[0080]
Next, in S55, print data to be printed on each medicine bag for each patient is created and stored in a predetermined file on the hard disk 9. At this time, the total amount of water, the total amount of ions, the total amount of calories, and the total amount of nitrogen are calculated for a plurality of types of injections contained in the medicine bag to be printed and stored in the above-mentioned predetermined file. Thereafter, the designated printer 4 performs a printing process on the medicine bag 26 (S56), and after all printing for the designated amount is completed, this routine ends. FIG. 22 shows the medicine bag 26 printed as described above, and the film material on the front side of the medicine bag 26 is formed of a transparent special film material that can be printed in color by an ink jet printer. In the upper part of the medicine bag 26, patient identification information, information related to a hospital room or a doctor, date / day of the week, application time zone (for example, “morning”) and the like are printed. Printed.
[0081]
As already described in the section of the pH fluctuation determination processing routine, for example, in the case of the example shown in FIG. 22, if “5-FU 250 mg” and “Bissorbon 4 mg” are mixed in the same syringe, pH fluctuation may occur. Therefore, "Bisorubon 4 mg" is described on the last line, separated by a dotted line.
[0082]
In the lower part of the medicine bag 26, information on "● Notes on pH in the same syringe: 3-2", which is a comment created in the pH fluctuation determination process, and a notice to ventilate the caution regarding contraindications " Please note that it may cause changes. ”, The text string“ Pisorbon 4mg Methicovar 500μg ”indicating the pair of injectable drugs that cause incompatibility detected in the incompatibility determination processing routine. The character string “Light orange red change (immediately after)” indicating the comment is printed. At the bottom of the medicine bag 26, information such as the total amount of water, the amount of ions of a plurality of ions, the calorie, the total amount of nitrogen, etc., which are calculated for a plurality of injections prescribed and contained in the medicine bag 26, are printed. Is done.
[0083]
The medicine bag 26 is a medicine bag for collectively accommodating one prescription injection for one patient, and various kinds of information as illustrated in FIG. 22 are printed on the medicine bag 26. In addition, notes on pH fluctuation, comments on contraindications, etc. are printed in red, for example, to ventilate the attention. The patient's name, date, day of the week, etc. are printed in large size letters. Therefore, since one prescription injection for one patient is stored in such a medicine bag 26, the correspondence between the patient, the application date, the application time zone, the injection, and the like is not mistaken, and the occurrence of a medication error is prevented. Can be reliably prevented.
[0084]
In addition, since the cautionary note of the pH fluctuation and the comment about the contraindications are printed on the medicine bag 26, it is possible to prevent the medicinal effect and the potency from being reduced due to the pH fluctuation, and to prevent the injection medicine from being colored due to the contraindications Injection drug costs can also be reduced because they are not disposed of even if they occur.
[0085]
Next, a label creation processing routine will be described with reference to FIGS. After the start of this routine, a predetermined initial screen is displayed, and a patient ID is input on the screen (S60). Next, in S61, a prescription for label creation is specified on the screen. At this time, since the window screen of FIG. 8 relating to the specified patient is displayed, the prescription is specified by inputting the data of the date and the application time zone or by specifying the data on the screen of FIG. In this S61, a plurality of prescriptions can be specified collectively.
[0086]
Next, in S62, patient identification data, prescription injection data corresponding to the specified prescription, and the like are read from the patient database DB3 and stored in the memory of the RAM 8. Next, patient identification data, date data, application time zone data, drug name data of prescription injections, etc. are arranged in a predetermined format, and data of print items for printing labels as shown in FIG. It is created, displayed on a screen, and temporarily stored in a memory (S63). Next, additional data such as notes and comments to be printed on the label are input as necessary (S64). However, if there is no need to input additional data, step S64 is omitted. Next, print data for label printing the displayed print item data and additional data is created and temporarily stored in a memory (S65). Next, label printing processing is executed by the designated printer 5 (S66), and when all printing for the designated print ends, this routine ends (S67).
[0087]
FIG. 24 shows two labels 28 created by the above label creation processing routine. The label 28 is a label to be attached to an infusion container such as a drip bottle. As the printing paper, a special peelable printing paper capable of forming a peelable label 28 is adopted. It can be easily peeled off and stuck to an infusion container, and if it is stuck to another infusion container by mistake, it can be easily peeled off.
[0088]
Here, an example in which the embodiment is partially changed will be described.
1) Although the various databases DB1 to DB4 are stored in files on the hard disk 9 of the personal computer 2, since the personal computer 2 can perform data communication with an external host computer by the communication interface 16, all of the databases DB1 to DB4 are stored. Alternatively, a part of the information can be stored in the host computer. Similarly, for the function achieving means 20 to 25, all or a part of those routines can be stored in the host computer. In such a case, the host computer also constitutes a part of the injection medicine dispensing support system.
[0089]
2) The data contents and structures in the various databases DB1 to DB4 are merely examples, and databases having different data contents and structures can be adopted without departing from the object of the present invention. The patient database DB3 may be constituted by a patient database of patients other than cancer patients and a database for cancer patients separately provided from this database.
3) The number of the printers 3 to 5 is not always required to be three, and one or two printers can be used as a matter of course.
[0090]
4) Regarding the anticancer drug adequacy determination routine, the calculation formula in S27 in FIG. 16 is an example, and a different simple calculation formula may be adopted. Further, 0.7 × K and 1.3 × K in the inequality for determination in S29 are merely examples, and an appropriate value between 0.70 and 0.95 can be adopted instead of 0.70. And an appropriate value between 1.05 and 1.30 can be adopted instead of 1.30.
[0091]
5) There may be provided a prescription data label creating means for printing out a chart pasting prescription data label 29 to any of the designated printers 3 to 5 using the information of the patient database DB3 as shown in FIG. . Since the label 29 is to be attached to a medical chart, it is printed on a rectangular release sheet of a predetermined size. The label 29 is printed with prescription information as shown in the figure for administering an injection or a drug other than the injection to the patient.
The prescription information printed on the label 29 is created based on the information in the patient database DB3. However, since the label 29 is visually checked at the pharmacy and then attached to the doctor's chart, Since it is printed neatly, it is effective in preventing mistakes in administration of medicines by nurses and doctors.
[0092]
6) The case where the injection medicine dispensing support system is installed in a pharmacy or a pharmacy of a hospital has been described as an example, but a personal computer of this injection medicine dispensing support system is connected so that data can be exchanged with personal computers of a plurality of doctors. In some cases, the doctor may be configured to be able to exchange various data, such as inputting and changing prescriptions and inputting comments. In addition, instead of installing the injection medicine dispensing support system in a pharmacy or pharmacy of a hospital, it may be installed in a dispensing pharmacy that performs dispensing work for a hospital.
However, the above-mentioned injection medicine dispensing support system is not always installed in a department that dispenses an injection medicine, but can also be installed in a ward. In this case, printed forms necessary for the department to be dispensed may be supplied to the department.
[0093]
7) The present invention is not limited to the above-described embodiments, and those skilled in the art can add various modifications to the above-described embodiments without departing from the spirit of the present invention. Yes, and the present invention covers those modifications.
[0094]
According to the first aspect of the present invention, the anticancer drug adequacy determining means uses the information of the injection drug master database and the patient database to prescribe the anticancer drug for each application for each cancer patient. Since it is possible to determine whether the amount and the application interval are appropriate, the injection drug dispensing support system is independent of the prescribing doctor, and the application interval and the prescribed amount of the anticancer agent prescribed to the cancer patient are appropriate. Therefore, it is possible to reliably detect a prescription error relating to the anticancer drug and prevent a medication error.
[0095]
According to the invention of claim 2, the anti-cancer drug adequacy determining means also determines whether or not the cumulative dose for each anti-cancer drug is equal to or less than the lifetime dose for each cancer patient. Since it is possible to check that the cumulative dose to each cancer patient does not exceed the lifetime dose, excessive administration of the anticancer drug can be reliably prevented.
[0096]
According to the invention of claim 3, in order to provide a combination contraindication database in which information about injection contraindications and combination contraindication phenomena for each of a plurality of types of injections is set in advance and stored in a storage medium. This makes it possible to know the combination of injections that are contraindicated when compounding an injection and the contraindications.
[0097]
According to the invention of claim 4, since the combination contraindication determination means is provided, it is possible to determine whether or not a combination contraindication occurs for a plurality of types of injections for each application applied to each patient. Disposal of injections can be reduced.
[0098]
According to the fifth aspect of the present invention, for example, a patient name, an application time zone (for example, morning, noon, evening), one or more injection medicine names, an injection medicine which causes a contraindication by the patient-specific application bag making means. It is possible to create a medicine bag printed with information such as the combination of the combination and its contraindicated phenomena (for example, cloudiness etc.). By storing the injection for one application in this medicine bag and supplying it to the nurse, It is possible to reliably prevent medication mistakes and the like.
[0099]
According to the invention of claim 6, the injection medicine master database has information on the amount of water contained in each injection medicine, the amount of ions of a plurality of types of ions, the amount of calories, and the total amount of nitrogen, so that one application dose can be obtained. Of total water content, total ion content, total caloric content, and total nitrogen content of multiple injections for multiple injections, and use that information effectively for prescribing by doctors and menus for hospitalized patients be able to.
[0100]
According to the invention of claim 7, the patient-specific application-specific medicine bag creating means includes a total water content and a total ion content and a total calorie content of a plurality of types of ions contained in one or a plurality of injections for each application. Since the total amount of total nitrogen is calculated and the information is also printed on the medicine bag for each patient, the information can be easily known, which is convenient when utilizing the information.
[0101]
According to the invention of claim 8, by the ward-based injection medicine total list creating means, a plurality of types of injection medicines applied in each time zone such as morning and afternoon in each of the plurality of wards are totaled by type, Since the list can be created, a plurality of types of injections to be supplied to each ward can be efficiently prepared, and the efficiency of dispensing work can be improved.
[0102]
According to the ninth aspect of the present invention, since the label creating means is provided, for example, the name of one or a plurality of injections, the application time zone (for example, morning, noon, evening), the patient name, and the like are printed. You can create an infusion label, and this infusion label is printed on peelable label paper, so it can be easily peeled off and pasted on an infusion container such as a drip bottle. It can be easily peeled off.
[Brief description of the drawings]
FIG. 1 is an external perspective view of an injection medicine dispensing support system according to an embodiment of the present invention.
FIG. 2 is a block diagram of an injection medicine dispensing support system.
FIG. 3 is an explanatory diagram showing a relationship between a plurality of databases and a plurality of function achieving means.
4A is a schematic explanatory diagram of an injection drug master database, FIG. 4B is a schematic explanatory diagram of a combination contraindicated database, FIG. 4C is a schematic explanatory diagram of a patient database, and FIG. FIG. 3 is an explanatory diagram of the outline of a database.
FIG. 5 is an explanatory diagram showing an example of injection medicine master data.
FIG. 6 is an explanatory diagram showing an example of combination prohibition data.
FIG. 7 is an explanatory diagram illustrating data contents of a patient database.
FIG. 8 is an explanatory diagram illustrating a part of a patient database.
FIG. 9 is an explanatory diagram of a daily dispensing amount list for each patient.
FIG. 10 is an explanatory diagram illustrating data contents of a patient database.
FIG. 11 is an explanatory diagram illustrating the contents of anticancer drug prescription history data for each patient.
FIG. 12 is a flowchart of a combination contraindication determination process.
FIG. 13 is an explanatory diagram illustrating an example of a judgment contraindication detected in the combination contraindication judgment processing.
FIG. 14 is a flowchart of a pH change process.
FIG. 15 is an explanatory diagram showing a display example of a pH fluctuation table.
FIG. 16 is a part of a flowchart of an anticancer agent appropriateness determination process.
FIG. 17 is the remaining part of the flowchart of the anticancer drug adequacy determination process.
FIG. 18 is a flowchart of a ward-specific injection medicine total list creation process.
FIG. 19 is an explanatory diagram showing a display example of a patient total table by ward.
FIG. 20 is an explanatory diagram illustrating a display example of a ward-specific injection medicine total list.
FIG. 21 is a flowchart of a process for creating a medicine bag for each patient.
FIG. 22 is a plan view of a printed medicine bag for each patient which is printed.
FIG. 23 is a flowchart of a label creation process.
FIG. 24 is a plan view of a printed label printed on special printing paper.
FIG. 25 is an explanatory diagram illustrating an example of printing a prescription data label for pasting a medical chart.
[Explanation of symbols]
1 Injection drug dispensing support system
2 personal computers
9 Hard disk
DB1 Injection Master Database
DB2 Combination contraindications database
DB3 Patient database
DB4 Anticancer drug prescription history database by patient
3-5 printer
20 Means for determining contraindications
22 Anticancer drug adequacy determination means
23 Injection medicine total list creation method by ward
24 Means for creating different medicine bags for each patient
25 Label making means

Claims (9)

In a system that assists a hospital in dispensing injections to multiple patients,
For each of the plurality of types of injections, drug identification information for specifying the injection and standard amount information are set in advance, and for a plurality of injections of anticancer drugs, application interval information and prescription for each anticancer drug are further added. An injection medicine master database in which a master coefficient for amount calculation is also set in advance and stored in a storage medium;
A patient database that stores patient identification information and injection prescription information for each of a plurality of patients in a storage medium, and further stores information on disease names and height and weight for cancer patients,
Using the information of the injection medicine master database and the patient database, for each cancer patient, the prescription amount of the anticancer drug for each application, and anticancer drug adequacy determining means for determining whether the application interval is appropriate,
Injection drug dispensing support system characterized by comprising: The injectable drug master database further includes, for the anticancer drug, lifetime dose information on a lifetime dose indicating a limit of the lifetime administration of each anticancer drug, and one or more anticancer drugs in each of a plurality of cancer patients. An anticancer drug prescribing history database in which prescription history information is stored in a storage medium is provided,
The anticancer drug adequacy determining means uses the data of the injection drug master database, the patient database, and the anticancer drug prescribing history database to determine whether the cumulative dose for each anticancer drug for each cancer patient is equal to or less than the lifetime dose. The injection medicine dispensing support system according to claim 1, wherein the determination is also made. 3. A combination contraindication database in which information on injection contraindications and combination contraindication phenomena which are contraindicated for each of a plurality of types of injections is set in advance and stored in a storage medium. Injection drug dispensing support system. Using the information of the injection medicine master database, the combination contraindication database and the patient database, a combination contraindication determining means for determining whether combination contraindications occur for a plurality of types of injections for each application applied to each patient is provided. The injection medicine dispensing support system according to claim 3, characterized in that: Using the information in the patient database, information on one or more types of injections for each application to be applied to each patient, application time zone information, patient identification information, and information on the incompatibility determined by the incompatibility determination means 5. The injection medicine dispensing support system according to claim 4, further comprising: a patient-specific application-specific medicine-bag creating means for preparing the patient-specific application-specific medicine-bag by printing the information on a predetermined medicine-specific bag. The injection medicine dispensing support system according to claim 5, wherein the injection medicine master database has information on a water amount, an ion amount of a plurality of types of ions, a caloric amount, and a total nitrogen amount contained in each injection medicine. . The patient-specific application-specific bag creating means calculates a total amount of water, a total amount of ions, a total amount of calories, and a total amount of total nitrogen contained in one or more injections for each application, 7. The injection medicine dispensing support system according to claim 6, wherein such information is also printed on a patient-specific medicine bag. In a system that assists a hospital in dispensing injections to multiple patients,
A patient database that stores patient identification information and injection prescription information for each of a plurality of patients in a storage medium, and for inpatients, further stores ward information for identifying inpatient wards of each patient,
Using the information of the patient database, a plurality of types of injectable drugs applied in each time zone such as morning and afternoon in each of a plurality of wards, tabulated by type, and a list of ward-specific injectable drugs to create a list thereof Creation means,
Injection drug dispensing support system characterized by comprising: Using the information of the patient database, prepare information on one or more injections to be mixed with the infusion to be applied to each patient, application time zone information, and patient identification information, and use the information as a predetermined peelable label. 9. The injection medicine dispensing support system according to claim 8, further comprising a label producing means for producing a label for infusion by printing on paper.

Images